Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
VTYX Quote, Financials, Valuation and Earnings
Last price:
$9.26
Seasonality move
:
50.12%
Day range:
$8.98 - $9.34
52-week range:
$0.78 - $10.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.45x
Volume:
488.8K
Avg. volume:
1.7M
1-year change:
297.42%
Market cap:
$660.8M
Revenue:
--
EPS (TTM):
-$1.50
Earnings Data
Next earnings date for VTYX
Feb 26
2026
Most recent earnings per share
-$0.32
Beat by $0.13
(Nov 6/2025)
Consensus Estimate
-$0.45
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VTYX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | -- | -- | -- | -$0.36 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.32 | -$0.45 | $0.13 |
| 08/08/2025 | Q2 | -- | -- | -$0.38 | -$0.47 | $0.09 |
| 05/08/2025 | Q1 | -- | -- | -$0.39 | -$0.48 | $0.10 |
| 02/27/2025 | Q4 | -- | -- | -$0.41 | -$0.55 | $0.13 |
| 11/07/2024 | Q3 | -- | -- | -$0.50 | -$0.51 | $0.01 |
| 08/08/2024 | Q2 | -- | -- | -$0.45 | -$0.57 | $0.12 |
| 05/09/2024 | Q1 | -- | -- | -$0.62 | -$0.65 | $0.03 |
| 02/27/2024 | Q4 | -- | -- | -$0.79 | -$0.80 | $0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.92 | -$0.88 | -$0.04 |
| 08/10/2023 | Q2 | -- | -- | -$0.91 | -$0.70 | -$0.21 |
| 05/11/2023 | Q1 | -- | -- | -$0.68 | -$0.64 | -$0.04 |
| 03/23/2023 | Q4 | -- | -- | -$0.62 | -$0.61 | -$0.01 |
| 11/03/2022 | Q3 | -- | -- | -$0.59 | -$0.45 | -$0.14 |
| 08/15/2022 | Q2 | -- | -- | -$0.39 | -$0.47 | $0.08 |
| 05/12/2022 | Q1 | -- | -- | -$0.45 | -- | -- |
| 03/23/2022 | Q4 | -- | -- | -$0.35 | -- | -- |
| 11/18/2021 | Q3 | -- | -- | -$0.27 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.74 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$1.86 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.79 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.34 | -- | -- |
Ventyx Biosciences, Inc. Earnings Questions
-
How Much did Ventyx Biosciences, Inc. Generate in Revenue Last Quarter?
Ventyx Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Ventyx Biosciences, Inc. Beat Earnings Last Quarter?
Ventyx Biosciences, Inc. announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.45 per share.
-
Is Ventyx Biosciences, Inc. Profitable?
Ventyx Biosciences, Inc. reported -$326K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Ventyx Biosciences, Inc. EPS Next Year?
Ventyx Biosciences, Inc.'s earnings are forecast to decrease from -$1.97 per share to -$1.44 per share next year representing a decrease of -26.81%.
-
When is Ventyx Biosciences, Inc.'s Earnings Date?
Ventyx Biosciences, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
